Ying-Zi Yang, PhD

Intellectual Property, Life Sciences, Artificial Intelligence


Dr. Ying-Zi Yang is extensively experienced with helping clients from pharmaceutical and biotechnology industries in a wide variety of ways. Her litigation experience includes representing clients in federal district court patent litigation cases, ITC Section 337 Actions, and USPTO post-grant proceedings.


Representative Federal Court, ITC, and PTAB Experience

  • Kinderfarms LLC v. Genexa Inc., PGR2023-00051
  • RiceTec Inc v. BASF SE, PGR2021-00113 and -0114
  • HemoSonics LLC v. CA Casyso GmbH, IPR2021-00293
  • Certain High-Potency Sweeteners, Processes for Making Same, and Products Containing Same; 337-TA-1264 (2021)
  • Astellas US LLC v. Imperial College Innovations Limited, IPR2020-00764
  • Celanese International Corporation et al v. Anhui Jinhe Industrial Co., Ltd. et al., D. Del. (2020)
  • C.A. Casyso GmbH v. HemoSonics LLC, CAFC (2020)


  • East China University of Science and Technology, BE, Chemical Engineering
  • New York University, Stern School of Business, MBA, Finance and Marketing
  • The City University of New York, PhD, Biochemistry
  • Fordham University School of Law, 法務博士


  • ニュージャージー州弁護士
  • ニューヨーク州弁護士


  • US Patent and Trademark Office
  • US District Court for the District of New Jersey
  • US Court of Appeals for the Federal Circuit


  • 英語
  • Chinese